Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Chutes and Ladders
Biotech
Lilly International's Patrik Jonsson to retire—Chutes & Ladders
Lilly vet retires after 36 years. Enanta CEO hangs up his hat. Estrella CEO to chip in on commercialization.
Donavyn Coffey
,
Marissa Russo
Oct 30, 2026 8:30am
GSK's Waterhouse tapped to helm struggling CSL—Chutes & Ladders
Oct 23, 2026 8:30am
Bausch + Lomb CEO heads for exit once more—Chutes & Ladders
Oct 16, 2026 8:30am
Paragon Labs imports Apogee leadership after AbbVie buyout
Oct 13, 2026 8:44am
Vir looks to Liu to lead late-stage push—Chutes & Ladders
Oct 9, 2026 8:30am
Bayer taps new chief medical officer—Chutes & Ladders
Oct 2, 2026 8:30am
